Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel–platinum
Authors:
- B. GronlundBGB. Gronlund
- L. LundvallLLL. Lundvall
- I.J. ChristensenICI.J. Christensen
- J.B. KnudsenJKJ.B. Knudsen
- C. HøgdallCHC. Høgdall
- 1 February 2005
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 31 (1) , 67-73
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Secondary cytoreductive surgery for recurrent epithelial ovarian cancerObstetrics & Gynecology, 2002
- Positron Emission Tomography for Detecting Clinically Occult Surgically Resectable Metastatic Ovarian CancerGynecologic Oncology, 2002
- Secondary Cytoreductive Surgery for Patients with Recurrent Epithelial Ovarian CarcinomaGynecologic Oncology, 2001
- Secondary Cytoreductive Surgery for Localized Intra-abdominal Recurrences in Epithelial Ovarian CancerGynecologic Oncology, 2001
- Complete Salvage Surgical Cytoreduction Improves Further Survival of Patients with Late Recurrent Ovarian CancerGynecologic Oncology, 2000
- Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancerEuropean Journal of Surgical Oncology, 2000
- Recurrent ovarian carcinoma: Is there a place for surgery?Seminars in Surgical Oncology, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Clinical trials in patients with epithelial ovarian cancer: past, present and futureEuropean Journal of Surgical Oncology, 1996
- Secondary cytoreductive surgery for recurrent epithelial ovarian cancerGynecologic Oncology, 1989